[Gestagen therapy of breast cancer. Effect of high doses on the blood coagulation system].
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D001943:Breast Neoplasms / Q000188:drug therapy*; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D008875:Middle Aged; D013924:Thrombophlebitis / Q000139:chemically induced*
D000970:Antineoplastic Agents; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone
Gestagen-Therapie des Mammakarzinoms. Einfluss hoher Dosen auf das Gerinnungssystem.